follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Matinas BioPharma moves to Bedminster

By

Back to Top Comments Email Print

Biopharmaceutical company Matinas BioPharma Holdings Inc. announced today it has established its corporate headquarters in Bedminster.

According to the announcement, the company, which recently closed a $15 million financing, is now positioned to begin advancing the development of omega-3 lead product candidate, MAT9001, for the treatment of severe hypertriglyceridemia and mixed dyslipidemia.

"We believe [establishing headquarters in New Jersey] strategically positions us very well to have access to great talent and the financial and pharmaceutical communities," Chief Executive Roelof Rongen said in a statement.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top